Garg Vipin K has filed 47 insider transactions across 1 company since January 2023.
Most recent transaction: a grant/award of 6926 shares of Altimmune, Inc. ($ALT) on January 31, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 31, 2026 | Altimmune, Inc. | $ALT | Garg Vipin K | Not found | A | Common Stock, par value $0.0001 | 6926 | $3.07 | 424,519.0000 | 88,104,132 | 1.66% | 0.01% |
| Jan. 30, 2026 | Altimmune, Inc. | $ALT | Garg Vipin K | Not found | F | Common Stock, par value $0.0001 | 11632 | $5.60 | 417,593.0000 | 88,104,132 | 2.71% | 0.01% |
| Jan. 30, 2026 | Altimmune, Inc. | $ALT | Garg Vipin K | Not found | M | Common Stock, par value $0.0001 | 26775 | $0.00 | 429,225.0000 | 88,104,132 | 6.65% | 0.03% |
| Jan. 30, 2026 | Altimmune, Inc. | $ALT | Garg Vipin K | Not found | M | Restricted Stock Units | 26775 | $0.00 | 26,775.0000 | 88,104,132 | 50.00% | 0.03% |
| Jan. 27, 2026 | Altimmune, Inc. | $ALT | Garg Vipin K | Not found | M | Restricted Stock Units | 41200 | $0.00 | 123,600.0000 | 88,104,132 | 25.00% | 0.05% |
| Jan. 27, 2026 | Altimmune, Inc. | $ALT | Garg Vipin K | Not found | F | Common Stock, par value $0.0001 | 17898 | $6.18 | 402,450.0000 | 88,104,132 | 4.26% | 0.02% |
| Jan. 27, 2026 | Altimmune, Inc. | $ALT | Garg Vipin K | Not found | M | Common Stock, par value $0.0001 | 41200 | $0.00 | 420,348.0000 | 88,104,132 | 10.87% | 0.05% |
| Jan. 25, 2026 | Altimmune, Inc. | $ALT | Garg Vipin K | Not found | M | Restricted Stock Units | 42050 | $0.00 | 84,100.0000 | 88,104,132 | 33.33% | 0.05% |
| Jan. 25, 2026 | Altimmune, Inc. | $ALT | Garg Vipin K | Not found | F | Common Stock, par value $0.0001 | 17984 | $5.50 | 379,148.0000 | 88,104,132 | 4.53% | 0.02% |
| Jan. 25, 2026 | Altimmune, Inc. | $ALT | Garg Vipin K | Not found | M | Common Stock, par value $0.0001 | 42050 | $0.00 | 397,132.0000 | 88,104,132 | 11.84% | 0.05% |
| Jan. 30, 2025 | Altimmune, Inc. | $ALT | Garg Vipin K | President and CEO | M | Common Stock, par value $0.0001 | 26775 | $0.00 | 342,696.0000 | 71,003,399 | 8.48% | 0.04% |
| Jan. 30, 2025 | Altimmune, Inc. | $ALT | Garg Vipin K | President and CEO | F | Common Stock, par value $0.0001 | 11701 | $7.00 | 330,995.0000 | 71,003,399 | 3.41% | 0.02% |
| Jan. 31, 2025 | Altimmune, Inc. | $ALT | Garg Vipin K | President and CEO | A | Common Stock, par value $0.0001 | 4105 | $5.18 | 335,100.0000 | 71,003,399 | 1.24% | 0.01% |
| Feb. 1, 2025 | Altimmune, Inc. | $ALT | Garg Vipin K | President and CEO | M | Common Stock, par value $0.0001 | 16545 | $0.00 | 351,645.0000 | 71,003,399 | 4.94% | 0.02% |
| Feb. 1, 2025 | Altimmune, Inc. | $ALT | Garg Vipin K | President and CEO | F | Common Stock, par value $0.0001 | 7231 | $6.64 | 344,414.0000 | 71,003,399 | 2.06% | 0.01% |
| Feb. 2, 2025 | Altimmune, Inc. | $ALT | Garg Vipin K | President and CEO | M | Common Stock, par value $0.0001 | 18950 | $0.00 | 363,364.0000 | 71,003,399 | 5.50% | 0.03% |
| Feb. 2, 2025 | Altimmune, Inc. | $ALT | Garg Vipin K | President and CEO | F | Common Stock, par value $0.0001 | 8282 | $6.64 | 355,082.0000 | 71,003,399 | 2.28% | 0.01% |
| Jan. 30, 2025 | Altimmune, Inc. | $ALT | Garg Vipin K | President and CEO | M | Restricted Stock Units | 26775 | $0.00 | 53,550.0000 | 71,003,399 | 100.00% | 0.04% |
| Feb. 1, 2025 | Altimmune, Inc. | $ALT | Garg Vipin K | President and CEO | M | Restricted Stock Units | 16545 | $0.00 | 0.0000 | 71,003,399 | 0.00% | 0.02% |
| Feb. 2, 2025 | Altimmune, Inc. | $ALT | Garg Vipin K | President and CEO | M | Restricted Stock Units | 18950 | $0.00 | 18,950.0000 | 71,003,399 | 9999.99% | 0.03% |
| Jan. 27, 2025 | Altimmune, Inc. | $ALT | Garg Vipin K | President and CEO | A | Restricted Stock Units | 164800 | $0.00 | 164,800.0000 | 71,003,399 | 9999.99% | 0.23% |
| Jan. 25, 2025 | Altimmune, Inc. | $ALT | Garg Vipin K | President and CEO | M | Common Stock, par value $0.0001 | 42050 | $0.00 | 334,078.0000 | 71,003,399 | 14.40% | 0.06% |
| Jan. 25, 2025 | Altimmune, Inc. | $ALT | Garg Vipin K | President and CEO | F | Common Stock, par value $0.0001 | 18157 | $6.98 | 315,921.0000 | 71,003,399 | 5.43% | 0.03% |
| Jan. 25, 2025 | Altimmune, Inc. | $ALT | Garg Vipin K | President and CEO | M | Restricted Stock Units | 42050 | $0.00 | 126,150.0000 | 71,003,399 | 50.00% | 0.06% |
| Jan. 27, 2025 | Altimmune, Inc. | $ALT | Garg Vipin K | President and CEO | A | Stock Options (option to buy) | 477500 | $0.00 | 477,500.0000 | 71,003,399 | 9999.99% | 0.67% |
| Feb. 2, 2024 | Altimmune, Inc. | $ALT | Garg Vipin K | President and CEO | M | Restricted Stock Units | 18950 | $0.00 | 37,900.0000 | 53,246,937 | 33.33% | 0.04% |
| Feb. 1, 2024 | Altimmune, Inc. | $ALT | Garg Vipin K | President and CEO | M | Restricted Stock Units | 16545 | $0.00 | 16,545.0000 | 53,246,937 | 50.00% | 0.03% |
| Feb. 2, 2024 | Altimmune, Inc. | $ALT | Garg Vipin K | President and CEO | F | Common Stock, par value $0.0001 | 8376 | $9.32 | 292,028.0000 | 53,246,937 | 2.79% | 0.02% |
| Feb. 2, 2024 | Altimmune, Inc. | $ALT | Garg Vipin K | President and CEO | M | Common Stock, par value $0.0001 | 18950 | $0.00 | 300,404.0000 | 53,246,937 | 6.73% | 0.04% |
| Feb. 1, 2024 | Altimmune, Inc. | $ALT | Garg Vipin K | President and CEO | F | Common Stock, par value $0.0001 | 7313 | $9.88 | 281,454.0000 | 53,246,937 | 2.53% | 0.01% |
| Feb. 1, 2024 | Altimmune, Inc. | $ALT | Garg Vipin K | President and CEO | M | Common Stock, par value $0.0001 | 16545 | $0.00 | 288,767.0000 | 53,246,937 | 6.08% | 0.03% |
| Jan. 30, 2024 | Altimmune, Inc. | $ALT | Garg Vipin K | President and CEO | M | Common Stock, par value $0.0001 | 26775 | $0.00 | 276,030.0000 | 53,246,937 | 10.74% | 0.05% |
| Jan. 30, 2024 | Altimmune, Inc. | $ALT | Garg Vipin K | President and CEO | M | Restricted Stock Units | 26775 | $0.00 | 80,325.0000 | 53,246,937 | 25.00% | 0.05% |
| Jan. 30, 2024 | Altimmune, Inc. | $ALT | Garg Vipin K | President and CEO | F | Common Stock, par value $0.0001 | 11697 | $9.80 | 264,333.0000 | 53,246,937 | 4.24% | 0.02% |
| Jan. 31, 2024 | Altimmune, Inc. | $ALT | Garg Vipin K | President and CEO | A | Common Stock, par value $0.0001 | 7889 | $2.69 | 272,222.0000 | 53,246,937 | 2.98% | 0.01% |
| Jan. 25, 2024 | Altimmune, Inc. | $ALT | Garg Vipin K | President and CEO | A | Restricted Stock Units | 168200 | $0.00 | 168,200.0000 | 53,246,937 | 9999.99% | 0.32% |
| Jan. 25, 2024 | Altimmune, Inc. | $ALT | Garg Vipin K | President and CEO | A | Stock Options (option to buy) | 470000 | $0.00 | 470,000.0000 | 53,246,937 | 9999.99% | 0.88% |
| July 31, 2023 | Altimmune, Inc. | $ALT | Garg Vipin K | President and CEO | A | Common Stock, par value $0.0001 | 126 | $2.81 | 249,255.0000 | 50,691,558 | 0.05% | 0.00% |
| Feb. 2, 2023 | Altimmune, Inc. | $ALT | Garg Vipin K | President and CEO | M | Restricted Stock Units | 18950 | $0.00 | 56,850.0000 | 46,926,349 | 25.00% | 0.04% |
| Feb. 2, 2023 | Altimmune, Inc. | $ALT | Garg Vipin K | President and CEO | M | Common Stock, par value $0.0001 | 18950 | $0.00 | 257,551.0000 | 46,926,349 | 7.94% | 0.04% |
| Feb. 2, 2023 | Altimmune, Inc. | $ALT | Garg Vipin K | President and CEO | F | Common Stock, par value $0.0001 | 8422 | $15.04 | 249,129.0000 | 46,926,349 | 3.27% | 0.02% |
| Feb. 1, 2023 | Altimmune, Inc. | $ALT | Garg Vipin K | President and CEO | M | Restricted Stock Units | 16546 | $0.00 | 33,090.0000 | 46,926,349 | 33.33% | 0.04% |
| Feb. 1, 2023 | Altimmune, Inc. | $ALT | Garg Vipin K | President and CEO | F | Common Stock, par value $0.0001 | 7658 | $13.78 | 238,601.0000 | 46,926,349 | 3.11% | 0.02% |
| Feb. 1, 2023 | Altimmune, Inc. | $ALT | Garg Vipin K | President and CEO | M | Common Stock, par value $0.0001 | 16546 | $0.00 | 246,259.0000 | 46,926,349 | 7.20% | 0.04% |
| Jan. 31, 2023 | Altimmune, Inc. | $ALT | Garg Vipin K | President and CEO | A | Common Stock, par value $0.0001 | 1938 | $10.21 | 229,713.0000 | 46,926,349 | 0.85% | 0.00% |
| Jan. 30, 2023 | Altimmune, Inc. | $ALT | Garg Vipin K | President and CEO | A | Restricted Stock Units | 107100 | $0.00 | 107,100.0000 | 46,926,349 | 9999.99% | 0.23% |
| Jan. 30, 2023 | Altimmune, Inc. | $ALT | Garg Vipin K | President and CEO | A | Stock Options (option to buy) | 302900 | $0.00 | 302,900.0000 | 46,926,349 | 9999.99% | 0.65% |